These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 2447442)

  • 1. Angiogenic activity by spleen cell supernatants from tumor-bearing and tumor-resected mice.
    Davel L; Miguez M; Jasnis MA; Eiján AM; Oisgold-Dagá S; Sacerdote de Lustig E
    J Surg Oncol; 1988 Jan; 37(1):44-8. PubMed ID: 2447442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of tumor growth by soluble spleen factors: effect of tumor resection.
    Jasnis MA; Elján AM; Oisgold-Dagá S
    J Surg Oncol; 1987 Jun; 35(2):139-45. PubMed ID: 3586684
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nature of the spleen cell populations capable of releasing tumor enhancing factor.
    Eiján AM; Jasnis MA; Kohan SS; Oisgold-Dagá S
    J Surg Oncol; 1987 Nov; 36(3):161-5. PubMed ID: 3500369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immunoregulation of tumor growth in a murine model].
    de Bonaparte YP; Colombo L; Davel L; Diament M; Eiján AM; Jasnis MA; Klein S; de Kohan SS; Oisgold-Daga S; Stillitani I
    Medicina (B Aires); 1989; 49(3):265-70. PubMed ID: 2487420
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunomodulation by soluble factors from tumor cells cultured in vivo in diffusion chambers.
    Klein S; Jasnis MA; Diament M; Davel L; Aguirre J; de Bonaparte YP
    Tumour Biol; 1994; 15(3):160-5. PubMed ID: 7521057
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lymphocyte-induced angiogenesis: correlation with the metastatic incidence of two murine mammary adenocarcinomas.
    Miguez M; Davel L; de Lustig ES
    Invasion Metastasis; 1986; 6(5):313-20. PubMed ID: 2430911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolated soluble fractions from spleen cell culture supernatants induce tumor enhancement.
    Eiján AM; Jasnis MA; Motta AB; Oisgold-Dagá S
    J Surg Oncol; 1989 Jun; 41(2):134-8. PubMed ID: 2724981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of lymphocyte-induced angiogenesis by free radical scavengers.
    Monte M; Davel LE; de Lustig ES
    Free Radic Biol Med; 1994 Sep; 17(3):259-66. PubMed ID: 7526998
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Modulation of angiogenesis induced by lymphocytes by extracellular matrix proteins].
    Eiján AM; Davel L; de Lustig ES
    Acta Physiol Pharmacol Ther Latinoam; 1993; 43(3-4):53-7. PubMed ID: 7540077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Production of BSF-1 during an in vivo, T-dependent immune response.
    Finkelman FD; Ohara J; Goroff DK; Smith J; Villacreses N; Mond JJ; Paul WE
    J Immunol; 1986 Nov; 137(9):2878-85. PubMed ID: 3489779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of Chlorella vulgaris on tumor growth in mammary tumor-bearing Balb/c mice: discussing association of an immune-suppressed protumor microenvironment with serum IFNγ and IgG decrease and spleen IgG potentiation.
    Khalilnezhad A; Mahmoudian E; Mosaffa N; Anissian A; Rashidi M; Amani D
    Eur J Nutr; 2018 Apr; 57(3):1025-1044. PubMed ID: 28229276
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lymphocyte-induced angiogenesis: effect of different antigenic stimuli.
    Davel LE; Jasnis MA
    Oncology; 1995; 52(3):226-9. PubMed ID: 7536319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A granulocytosis-inducing tumor inhibits the production of B lymphocytes in murine bone marrow.
    Fülöp G; Lee MY; Rosse C
    J Immunol; 1985 Dec; 135(6):4266-72. PubMed ID: 3877765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reactivity of tumor-draining lymph nodes and the nitric oxide pathway.
    Davel L; Eijan AM; Sales ME; Español A; D'Agostino A; Piccardo I; Lauría L; De Lustig ES; Jasnis MA
    Int J Oncol; 2002 Jan; 20(1):59-67. PubMed ID: 11743643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Thymic involution and thymocyte phenotypic alterations induced by murine mammary adenocarcinomas.
    Fu Y; Paul RD; Wang Y; Lopez DM
    J Immunol; 1989 Dec; 143(12):4300-7. PubMed ID: 2592775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An antiserum to tumour angiogenesis factor: therapeutic approach to solid tumours.
    Battiwalla ZF; Shethna YI
    Anticancer Res; 1989; 9(6):1809-13. PubMed ID: 2483305
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Muscarinic receptors autoantibodies purified from mammary adenocarcinoma-bearing mice sera stimulate tumor progression.
    Fiszman G; Cattaneo V; de la Torre E; Español A; Colombo L; Sacerdote de Lustig E; Sales ME
    Int Immunopharmacol; 2006 Aug; 6(8):1323-30. PubMed ID: 16782546
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expansion of immunoregulatory macrophages by granulocyte-macrophage colony-stimulating factor derived from a murine mammary tumor.
    Fu YX; Watson G; Jimenez JJ; Wang Y; Lopez DM
    Cancer Res; 1990 Jan; 50(2):227-34. PubMed ID: 2136804
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polyamines prevent DFMO-mediated inhibition of angiogenesis.
    Jasnis MA; Klein S; Monte M; Davel L; Sacerdote de Lustig E; Algranati ID
    Cancer Lett; 1994 Apr; 79(1):39-43. PubMed ID: 7514492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of lymphocyte subsets in spontaneous mouse mammary tumors and host lymphoid organs.
    Santer V; Mastromarino JH; Lala PK
    Int J Cancer; 1980 Jan; 25(1):159-68. PubMed ID: 6967460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.